Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on m aminophenylacetylene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103724211A reveals a cost-effective route for m-aminophenylacetylene using m-nitrobenzaldehyde, offering significant supply chain advantages for API manufacturers.
Novel patent CN104193689A offers cost-effective Erlotinib synthesis. Avoids palladium catalysts. Ensures supply chain stability for pharmaceutical intermediates.
Discover how palladium-catalyzed carbonylation enables efficient indole-3-carboxamide synthesis with 85-92% yield, reducing production costs and supply chain risks for pharmaceutical intermediates.